[1] |
Goldhaber SZ. Evolving concepts in thrombolytic therapy for pulmonary embolism[J]. Chest, 1992, 101(4 Suppl): 183S-185S.
|
[2] |
White RH. The epidemiology of venous thromboembolism[J]. Circulation, 2003, 107(23 Suppl 1): 14-18.
|
[3] |
McRae S. Treatment options for venous thromboembolism: lessons learnt from clinical trials[J]. Thromb J, 2014, 12(1): 27.
|
[4] |
Deitelzweig SB, Johnson BH, Lin J, et al. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections[J]. Am J Hematol, 2011, 86(2): 217-220.
|
[5] |
Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality[J]. Thromb Haemost, 2007, 98(4): 756-764.
|
[6] |
Patel R, Cook DJ, Meade MO, et al. Burden of illness in venous thromboembolism in critical care: a multicenter observational study[J]. J Crit Care, 2005, 20(4): 341-347.
|
[7] |
Attia J, Ray JG, Cook DJ, et al. Deep vein thrombosis and its prevention in critically ill adults[J]. Arch Intern Med, 2001, 161(10): 1268-1279.
|
[8] |
Rolston JD, Han SJ, Lau CY, et al. Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011[J]. J Neurosurg, 2014, 120(3): 736-745.
|
[9] |
Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke[J]. Stroke, 2001, 32(1): 262-267.
|
[10] |
Brandes AA, Scelzi E, Salmistraro G, et al. Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study[J]. Eur J Cancer, 1997, 33(10): 1592-1596.
|
[11] |
Dhami MS, Bona RD, Calogero JA, et al. Venous thromboembolism and high grade gliomas[J]. Thromb Haemost, 1993, 70(3): 393-396.
|
[12] |
Bleau N, Patenaude V, Abenhaim HA. Risk of Venous thromboembolic events in pregnant patients with autoimmune diseases: a population-based study[J]. Clin Appl Thromb Hemost, 2016, 22(3): 285-291
|
[13] |
Elkind MS. Inflammatory mechanisms of stroke[J]. Stroke 2010, 41(10 Suppl): S3-S8.
|
[14] |
Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association[J]. Circulation, 2012, 125(1): 188-197.
|
[15] |
Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association[J]. Circulation, 2012, 125(1): 188-197.
|
[16] |
Roger VL, O’Donnell CJ. Population health, outcomes research, and prevention: example of the American Heart Association 2020 goals[J]. Circ Cardiovasc Qual Outcomes, 2012, 5(1): 6-8.
|
[17] |
Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke[J]. Mayo Clin Proc, 1997, 72(4): 297-300.
|
[18] |
Indredavik B, Rohweder G, Naalsund E, et al. Medical complications in a comprehensive stroke unit and an early supported discharge service[J]. Stroke, 2008, 39(2): 414-420.
|
[19] |
Minino AM, Murphy SL, Xu J, et al. Deaths: final data for 2008[J]. Natl Vital Stat Rep, 2011, 59(10): 1-126.
|
[20] |
Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013, 44(3): 870-947.
|
[21] |
Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl): 7S-47S.
|
[22] |
Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison[J]. Lancet, 2007, 369(9570): 1347-1355.
|
[23] |
Dennis M, Sandercock P, Reid J, et al. The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2[J]. Stroke, 2013, 44(4): 1075-1079.
|
[24] |
Dennis M, Sandercock P, Reid J, et al. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke(CLOTS 3): a multicentre randomised controlled trial[J]. Lancet, 2013, 382(9891): 516-524.
|
[25] |
Sandercock PA, van den Belt AG, Lindley RI, et al. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials[J]. J Neurol Neurosurg Psychiatry, 1993, 56(1): 17-25.
|
[26] |
Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. a metaanalysis of randomized, controlled trials[J]. Ann Intern Med, 1999, 130(10): 800-809.
|
[27] |
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy[J]. Chest, 2004, 126(3 Suppl): 338S-400S.
|
[28] |
Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of venous thromboembolism after acute ischemic stroke[J]. J Thromb Haemost, 2005, 3(6): 1187-1194.
|
[29] |
Mazzone C, Chiodo GF, Sandercock P, et al. Physical methods for preventing deep vein thrombosis in stroke[J]. Cochrane Database Syst Rev, 2004(4): CD001922.
|
[30] |
Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients[J]. Neurology, 1998, 50(6): 1683-1688.
|
[31] |
Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism International Consensus Statement (Guidelines according to scientific evidence)[J]. Int Angiol, 2006, 25(2): 101-161.
|
[32] |
Epstein NE. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery[J]. Surg Neurol, 2005, 64(4): 295-301.
|
[33] |
Agnelli G. Prevention of venous thromboembolism after neurosurgery[J]. Thromb Haemost, 1999, 82(2): 925-930.
|
[34] |
Frim DM, Barker FG, Poletti CE, et al. Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients[J]. Neurosurgery, 1992, 30(6): 830-832.
|
[35] |
Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following acute intracerebral hemorrhage[J]. Neurocrit Care, 2009, 10(1): 28-34.
|
[36] |
Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke[J]. Am J Phys Med Rehabil. 2003, 82(5): 364-349.
|
[37] |
Kim KS, Brophy GM. Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage[J]. Neurocrit Care, 2009, 11(1): 28-33.
|
[38] |
Skaf E, Stein PD, Beemath A, et al. Venous thromboembolism in patients with ischemic and hemorrhagic stroke[J]. Am J Cardiol, 2005, 96(12): 1731-1733.
|
[39] |
Diringer MN, Skolnick BE, Mayer SA, et al. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the factor seven for acute hemorrhagic stroke (FAST) trial[J]. Stroke, 2010, 41(1): 48-53.
|
[40] |
Kawase K, Okazaki S, Toyoda K, et al. Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage[J]. Cerebrovasc Dis, 2009, 27(4): 313-319.
|
[41] |
Ogata T, Yasaka M, Wakugawa Y, et al. Deep venous thrombosis after acute intracerebral hemorrhage[J]. J Neurol Sci, 2008: 272(1-2): 83-86.
|
[42] |
Lyden PD, Shuaib A, Lees KR, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial[J]. Stroke, 2007, 38(8): 2262-2269.
|
[43] |
Maramattom BV, Weigand S, Reinalda M, et al. Pulmonary complications after intracerebral hemorrhage[J]. Neurocrit Care, 2006, 5(2): 115-119.
|
[44] |
Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage[J]. Neurology, 2005, 65(6): 865-869.
|
[45] |
Dennis M, Sandercock PA, Reid J, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial[J]. Lancet, 2009, 373(9679): 1958-1965.
|
[46] |
Boeer A, Voth E, Henze T, et al. Early heparin therapy in patients with spontaneous intracerebral haemorrhage[J]. J Neurol Neurosurg Psychiatry, 1991, 54(5): 466-467.
|
[47] |
Orken DN, Kenangil G, Ozkurt H, et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage[J]. Neurologist, 2009, 15(6): 329-331.
|
[48] |
O’Carroll CB, Capampangan DJ, Aguilar MI, et al. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic[J]. Neurologist, 2011, 17(4): 232-235.
|
[49] |
Paciaroni M, Agnelli G, Venti M, et al. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies[J]. J Thromb Haemost, 2011, 9(5): 893-898.
|
[50] |
Tetri S, Hakala J, Juvela S, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage[J]. Thromb Res, 2008, 123(2): 206-212.
|
[51] |
Wasay M, Khan S, Zaki KS, et al. A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral haemorrhage[J]. J Pak Med Assoc, 2008, 58(7): 362-364.
|
[52] |
Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl): e601S-e636S.
|
[53] |
Dickmann U, Voth E, Schicha H, et al. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage[J]. Klinische Wochenschr, 1988, 66(23): 1182-1183.
|
[54] |
Kshettry VR, Rosenbaum BP, Seicean A, et al. Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage[J]. J Clin Neurosci, 2014, 21(2): 282-286.
|
[55] |
Ray WZ, Strom RG, Blackburn SL, et al. Incidence of deep venous thrombosis after subarachnoid hemorrhage[J]. J Neurosurg, 2009, 110(5): 1010-1014.
|
[56] |
Mack WJ, Ducruet AF, Hickman ZL, et al. Doppler ultrasonography screening of poor-grade subarachnoid hemorrhage patients increases the diagnosis of deep venous thrombosis[J]. Neurol Res, 2008, 30(9): 889-892.
|
[57] |
Vespa P. Deep venous thrombosis prophylaxis[J]. Neurocrit Care, 2011, 15(2): 295-297.
|
[58] |
Olkowski BF, Devine MA, Slotnick LE, et al. Safety and feasibility of an early mobilization program for patients with aneurysmal subarachnoid hemorrhage[J]. Phys Ther, 2013, 93(2): 208-215.
|
[59] |
Collen JF, Jackson JL, Shorr AF, et al. Prevention of venous thromboembolism in neurosurgery: a metaanalysis[J]. Chest, 2008, 134(2): 237-249.
|
[60] |
Qaseem A, Chou R, Humphrey LL, et al. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians[J]. Ann Intern Med, 2011, 155(9): 625-632.
|
[61] |
Abdullah JM, Zainuddin N, Sulong S, et al. Molecular genetic analysis of phosphatase and tensin homolog and p16 tumor suppressor genes in patients with malignant glioma[J]. Neurosurg Focus, 2003, 14(4): e6.
|
[62] |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference[J]. Neurocrit Care, 2011, 15(2): 211-240.
|
[63] |
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl): e227S-e277S.
|
[64] |
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl): 381S-453S.
|
[65] |
Gearhart MM, Luchette FA, Proctor MC, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis[J]. Surgery, 2000, 128(4): 631-640.
|
[66] |
Knudson MM, Ikossi DG, Khaw L, et al. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank[J]. Ann Surg, 2004, 240(3): 490-496.
|
[67] |
Sharma OP, Oswanski MF, Joseph RJ, et al. Venous thromboembolism in trauma patients[J]. Am Surg, 2007, 73(11): 1173-1180.
|
[68] |
Imberti D, Ageno W. A survey of thromboprophylaxis management in patients with major trauma[J]. Pathophysiol Haemost Thromb, 2005, 34(6): 249-254.
|
[69] |
Nathens AB, McMurray MK, Cuschieri J, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient[J]. J Trauma, 2007, 62(3): 557-562.
|
[70] |
Reiff DA, Haricharan RN, Bullington NM, et al. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis[J]. J Trauma, 2009, 66(5): 1436-1440.
|
[71] |
Rogers FB, Cipolle MD, Velmahos G, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group[J]. J Trauma, 2002, 53(1): 142-164.
|
[72] |
Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy[J]. J Neurotrauma, 2007, 24(Suppl 1): S14-S20.
|
[73] |
Simanek R, Vormittag R, Hassler M, et al. Venous thromboembolism and survival in patients with high-grade glioma[J]. Neurooncology, 2007, 9(2): 89-95.
|
[74] |
Robins HI, O’Neill A, Gilbert M, et al. Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial[J]. Cancer Chemother Pharmacol, 2008, 62(2): 227-233.
|
[75] |
Perry SL, Bohlin C, Reardon DA, et al. Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients[J]. J Neurooncol, 2009, 95(1): 129-134.
|
[76] |
Perry JR, Julian JA, Laperriere NJ, et al. PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma[J]. J Thromb Haemost, 2010, 8(9): 1959-1965.
|
[77] |
Cage TA, Lamborn KR, Ware ML, et al. Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas[J]. J Neurooncol, 2009, 93(1): 151-156
|
[78] |
Miranda AR, Hassouna HI. Mechanisms of thrombosis in spinal cord injury[J]. Hematol Oncol Clin North Am, 2000, 14(2): 401-416.
|
[79] |
Aito S, Pieri A, D’Andrea M, et al. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients[J]. Spinal Cord, 2002, 40(6): 300-303.
|
[80] |
Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin[J]. Ann Intern Med, 1990, 113(8): 571-574.
|
[81] |
Merli GJ, Crabbe S, Doyle L, et al. Mechanical plus pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury[J]. Paraplegia, 1992, 30(8): 558-562.
|
[82] |
Wilson JT, Rogers FB, Wald SL, et al. Prophylactic vena cava filter insertion in patients with traumatic spinal cord injury: preliminary results[J]. Neurosurgery, 1994, 35(2): 234-239.
|
[83] |
Khansarinia S, Dennis JW, Veldenz HC, et al. Prophylactic Greenfield filter placement in selected high-risk trauma patients[J]. J Vasc Surg. 1995, 22(3): 231-235.
|
[84] |
Rogers FB, Shackford SR, Ricci MA, et al. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism[J]. J Am Coll Surg, 1995, 180(6):641-647.
|
[85] |
Harris S, Chen D, Green D. Enoxaparin for thromboembolism prophylaxis in spinal injury: preliminary report on experience with 105 patients[J]. Am J Phys Med Rehabil, 1996, 75(5): 326-327.
|
[86] |
Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecularweight heparin as prophylaxis against venous thromboembolism after major trauma[J]. N Engl J Med, 1996, 335(10): 701-707.
|
[87] |
Consortium for Spinal Cord Medicine. Prevention of thromboembolism in spinal cord injury. 2nd ed, Washington, DC: Paralyzed Veterans of America: 1999.
|
[88] |
Worley S, Short C, Pike J, et al. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study[J]. Journal Spinal Cord Med, 2008, 31(4): 379-387.
|
[89] |
Wade WE, Chisholm MA. Venous thrombosis after acute spinal cord injury: cost analysis of prophylaxis guidelines[J]. Am J Phys Med Rehabil, 2000, 79(6): 504-508.
|
[90] |
Kahn SR, Lim W, Dunn AS, et al. Prevention of vte in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2_suppl): e195S-e226S.
|
[91] |
Gaber TA, Kirker SG, Jenner JR. Current practice of prophylactic anticoagulation in Guillain-Barre syndrome[J]. Clin Rehabil, 2002, 16(2): 190-193.
|
[92] |
Henderson RD, Lawn ND, Fletcher DD, et al. The morbidity of Guillain-Barre syndrome admitted to the intensive care unit[J]. Neurology, 2003, 60(1): 17-21.
|
[93] |
Hewer RL, Hilton PJ, Smith AC, et al. Acute polyneuritis requiring artificial respiration[J]. Q J Med. 1968, 37(147): 479-491.
|
[94] |
Ng KK, Howard RS, Fish DR, et al. Management and outcome of severe Guillain-Barre syndrome[J]. QJM, 1995, 88(4): 243-250.
|
[95] |
Moore P, James O. Guillain-Barre syndrome: incidence, management and outcome of major complications[J]. Crit Care Med, 1981, 9(7): 549-555.
|
[96] |
Ropper AH, Kehne SM. Guillain-Barre syndrome: management of respiratory failure[J]. Neurology, 1985, 35(11): 1662-1665.
|
[97] |
Alikhan R, Cohen AT. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)[J]. Cochrane Database Syst Rev, 2009(3): CD003747.
|
[98] |
King CS, Holley AB, Jackson JL, et al. Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: a metaanalysis[J]. Chest, 2007, 131(2): 507-516.
|
[99] |
Phung OJ, Kahn SR, Cook DJ, et al. Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis[J]. Chest, 2011, 140(2): 374-381.
|
[100] |
Wein L, Wein S, Haas SJ, et al. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials[J]. Arch Intern Med, 2007, 167(14): 1476-1486.
|
[101] |
Kakkos SK, Caprini JA, Geroulakos G, et al Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients[J]. CochraneDatabase Syst Rev, 2008, (4): CD005258.
|
[102] |
Sachdeva A, Dalton M, Amaragiri SV, et al. Elastic compression stockings for prevention of deep vein thrombosis[J]. Cochrane Database Syst Rev, 2010, (7): CD001484.
|
[103] |
Cook D, Meade M, Guyatt G, et al. Dalteparin versus unfractionated heparin in critically ill patients[J]. N Engl J Med, 2011, 364(14): 1305-1314.
|
[104] |
Dearborn JT, Hu SS, Tribus CB, et al. Thromboembolic complications after major thoracolumbar spine surgery[J]. Spine, 1999, 24(14): 1471-1476.
|
[105] |
Glotzbecker MP, Bono CM, Wood KB, et al. Thromboembolic disease in spinal surgery: a systematic review[J]. Spine, 2009, 34(3): 291-303.
|
[106] |
Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism[J]. Chest, 2001, 119(1 Suppl): 132S-175S.
|
[107] |
Agnelli G. Prevention of venous thromboembolism in surgical patients[J]. Circulation, 2004, 110(24 Suppl 1): IV4-IV12.
|
[108] |
Smith JS, Fu KMG, Polly DW, et al. Complication rates of three common spine procedures and rates of thromboembolism following spine surgery based on 108, 419 procedures: a report from the scoliosis research society morbidity and mortality committee[J]. Spine, 2010, 35(24): 2140-2149.
|
[109] |
Quevedo JF, Buckner JC, Schmidt JL, et al. Thromboembolism in patients with high-grade glioma[J]. Mayo Clin Proc, 1994, 69(4): 329-332.
|
[110] |
Semrad TJ, O’Donnell R, Wun T, et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma[J]. J Neurosurg, 2007, 106(4): 601-608.
|
[111] |
Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis[J]. Arch Intern Med, 2000, 160(15): 2327-2332.
|
[112] |
Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery[J]. N Engl J Med, 1998, 339(2): 80-85.
|
[113] |
Nurmohamed MT, van Riel AM, Henkens CM, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery[J]. Thromb Haemost, 1996, 75(2): 233-238.
|
[114] |
Paoletti C, Maubec E, Raggueneau JL, et al. Clinical tolerance of CY 216 (Fraxiparin) in the prevention of thromboembolic accidents after neurosurgery[J]. Agressologie, 1989, 30(6): 363-366.
|
[115] |
Voth D, Schwarz M, Hahn K, et al. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen[J]. Neurosurgical review, 1992, 15(4): 289-294.
|
[116] |
Barnett HG, Clifford JR, Llewellyn RC. Safety of mini-dose heparin administration for neurosurgical patients[J]. J Neurosurg, 1977, 47(1): 27-30.
|
[117] |
Bostrom S, Holmgren E, Jonsson O, et al. Post-operative thromboembolism in neurosurgery. a study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin[J]. Acta Neurochir (Wien), 1986,80(3-4): 83-89.
|
[118] |
Cerrato D, Ariano C, Fiacchino F. Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients[J]. J Neurosurg. 1978, 49(3): 378-381.
|
[119] |
Bynke O, Hillman J, Lassvik C. Does peroperative external pneumatic leg muscle compression prevent post-operative venous thrombosis in neurosurgery[J]? Acta Neurochir (Wien), 1987, 88(1-2): 46-48.
|
[120] |
Skillman JJ, Collins RE, Coe NP, et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots[J]. Surgery, 1978, 83(3): 354-358.
|
[121] |
Kshettry VR, Rosenbaum BP, Seicean A, et al. Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage[J]. J Clin Neurosci, 2014, 21(2): 282-286.
|
[122] |
Epstein NE. Efficacy of pneumatic compression stocking prophylaxis in the prevention of deep venous thrombosis and pulmonary embolism following 139 lumbar laminectomies with instrumented fusions[J]. J Spinal Disord Tech, 2006, 19(1): 28-31.
|
[123] |
Nelson LD Jr, Montgomery SP, Dameron TB Jr, et al. Deep vein thrombosis in lumbar spinal fusion: a prospective study of antiembolic and pneumatic compression stockings[J]. J South Orthop Assoc, 1996, 5(3): 181-184.
|
[124] |
Turpie AG, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis in potential neurosurgical patients. a randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control[J]. Arch Intern Med, 1989, 149(3): 679-681.
|
[125] |
Wood KB, Kos PB, Abnet JK, et al. Prevention of deep-vein thrombosis after major spinal surgery: a comparison study of external devices[J]. J Spinal Disord, 1997, 10(3): 209-214.
|
[126] |
Ferree BA, Wright AM. Deep venous thrombosis following posterior lumbar spinal surgery[J]. Spine, 1993, 18(8): 1079-1082.
|
[127] |
Ferree BA. Deep venous thrombosis following lumbar laminotomy and laminectomy[J]. Orthopedics, 1994, 17(1): 35-38.
|
[128] |
Ferree BA, Stern PJ, Jolson RS, et al. Deep venous thrombosis after spinal surgery[J]. Spine, 1993, 18(3): 315-319.
|
[129] |
Wen DY, Hall WA. Complications of subcutaneous low-dose heparin therapy in neurosurgical patients[J]. Surg Neurol, 1998, 50(6): 521-525.
|
[130] |
Dickinson LD, Miller LD, Patel CP, et al. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors[J]. Neurosurgery, 1998, 43(5): 1074-1081.
|
[131] |
Constantini S, Kanner A, Friedman A, et al. Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study[J]. J Neurosurg, 2001, 94(6): 918-921.
|
[132] |
Macdonald RL, Amidei C, Baron J, et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy[J]. Surg Neurol, 2003, 59(5): 363-372.
|
[133] |
Macdonald RL, Amidei C, Lin G, et al. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy[J]. Neurosurgery, 1999, 45(2): 245-251.
|
[134] |
Minshall CT, Eriksson EA, Leon SM, et al. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score>2[J]. J Trauma, 2011, 71(2): 396-399.
|
[135] |
Nurmohamed MT, ten Cate H, ten Cate JW. Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations[J]. Drugs, 1997, 53(5): 736-751.
|
[136] |
Rokito SE, Schwartz MC, Neuwirth MG. Deep vein thrombosis after major reconstructive spinal surgery[J]. Spine, 1996, 21(7): 853-858.
|
[137] |
Rosner MK, Kuklo TR, Tawk R, et al. Prophylactic placement of an inferior vena cava filter in high-risk patients undergoing spinal reconstruction[J]. Neurosurg Focus, 2004, 17(4): E6.
|
[138] |
Ozturk C, Ganiyusufoglu K, Alanay A, et al. Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery[J]. Spine, 2010, 35(20): 1893-1896.
|
[139] |
Gorman PH, Qadri SF, Rao-Patel A. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury[J]. J Trauma, 2009, 66(3): 707-712.
|
[140] |
Britt LD, Zolfaghari D, Kennedy E, et al. Incidence and prophylaxis of deep vein thrombosis in a high risk trauma population[J]. Am J Surg, 1996, 172(1): 13-14.
|
[141] |
Goldhaber SZ, Dunn K, Gerhard-Herman M, et al. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis[J]. Chest, 2002, 122(6): 1933-1937.
|
[142] |
Hoh BL, Nogueira RG, Ledezma CJ, et al. Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement[J]. Neurosurgery, 2005, 57(5): 845-849.
|